Beginning in 1996, the cholesterol-reducing drug Lipitor has been prescribed to patients who are fighting high cholesterol. The drug is manufactured and marketed by Pfizer. Sales of the drug have reached into the billions, with millions of patients taking the medication. Unfortunately, there is a link between use of the medication and the risk of developing increased blood sugar levels, and ultimately, type 2 diabetes. Type 2 diabetes is a potentially dangerous condition that requires frequent monitoring, medical treatment, and lifestyle changes. As a result of this suffering, some patients are now pursuing lawsuits against Pfizer.
5 Accusations Being Made Against Pfizer Over Lipitor Use
What are some of the accusations being made against the company? The following is an overview:
- The maker of Lipitor knew, or should have known, about the risk of developing type 2 diabetes as a result of taking the drug. Regardless, the company ignored those risks.
- When designing, developing, manufacturing, testing, packaging, promoting, marketing, distributing, labeling, and selling Lipitor, Pfizer engaged in negligent and wrongful conduct.
- Pfizer owed a duty to patients using the drug to monitor its safety. The company failed to fulfill this obligation.
- When marketing the drug, Pfizer used overly aggressive and misleading tactics. At the same time, the company did not provide patients or physicians with crucial information that could have prevented their injuries.
- When Pfizer originally created the labels and prepared the prescribing information for Lipitor, it did not warn patients of the potential correlation between increased blood sugar levels and use of the drug. Patients were also not warned about the serious risk of developing type 2 diabetes. The drug was distributed with these inadequate labels for many years, between 1996 and 2012.
To receive up-to-date information on all of the latest information about dangerous drugs, we encourage you to find and follow us on Twitter today.
|
Related Links:
|